Envisagenics

Long Island City, United States · Founded 2014 · $31.4M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$31.4M
Last Round
$25.0M Series BJun 2024
Rounds
6

About

AI-driven biotechnology company discovering RNA splicing targets and developing therapeutics for oncology and neurodegeneration.

Summary

Envisagenics is an Artificial Intelligence company based in Long Island City, United States, founded in 2014. It has raised $31.4M in total across 6 rounds, most recently a $25.0M Series B round in Jun 2024. Investors include Third Kind Venture Capital, Red Cell Partners and Dynamk Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJun 2024
$25.0M

Sign up to see all 6 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Envisagenics on Indexed.vc
<a href="https://indexed.vc/companies/envisagenics"><img src="https://indexed.vc/api/badge/company/envisagenics" alt="Envisagenics on Indexed.vc" width="260" height="76" /></a>